As of 2025-06-13, the Intrinsic Value of Forma Therapeutics Holdings Inc (FMTX) is -19.87 USD. This FMTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 20.01 USD, the upside of Forma Therapeutics Holdings Inc is -199.29%.
Based on its market price of 20.01 USD and our intrinsic valuation, Forma Therapeutics Holdings Inc (FMTX) is overvalued by 199.29%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -19.87 - -19.87 | -19.87 | -199.29% |
| P/E | (63.58) - (106.89) | (90.30) | -551.3% |
| DDM - Stable | (22.32) - (57.30) | (39.81) | -298.9% |
| DDM - Multi | (17.24) - (35.57) | (23.34) | -216.6% |
| Market Cap (mil) | 957.53 |
| Beta | 1.04 |
| Outstanding shares (mil) | 47.85 |
| Enterprise Value (mil) | 882.39 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.35% |
| Cost of Debt | 5.00% |
| WACC | 8.74% |